aminon

Known as: 4-(4-(bis(4-(dimethylamino)phenyl)hydroxymethyl)- 4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl) benzenesulfonic acid ammonium salt 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1976-2017
01219762017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
In this study, 4-[5-aryl-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl] benzenesulfonamides were synthesized, and inhibition… (More)
  • table 3
Is this relevant?
2017
2017
4-(3-(4-Substituted-phenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl) benzenesulfonamides (9-16) were successfully synthesized and… (More)
  • table 1
Is this relevant?
2017
2017
BACKGROUND Cyclooxygenase (COX-2) inhibitors have been developed to provide better anti-inflammatory and analgesic efficacy than… (More)
Is this relevant?
2015
2015
4-(Pyridin-3-yl)-1H-pyrazol-1-yl-phenyl-3-benzamide derivatives have been proposed as new BCR-ABL tyrosine kinase inhibitors by… (More)
Is this relevant?
2014
2014
C-C chemokine receptor type 1 (CCR1) is a chemokine receptor with seven transmembrane helices and it belongs to the G-Protein… (More)
  • table 2
  • table 1
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2008
2008
A new series of 1,3-dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives has been identified as potent A(2B… (More)
Is this relevant?
2007
2007
In the present work, a theoretical study of five bipyrazolic-type organic compounds, 4-{bis[(3,5-dimethyl-1H-pyrazolyl-1-yl… (More)
Is this relevant?
2006
2006
Synthesis and biological evaluation of possible prodrugs of COX-2 inhibitors involving sulfonamide and hydroxymethyl groups of 2… (More)
Is this relevant?
2004
2004
During the impurity profile of Celecoxib, four polar impurities (impurity I, II, III and IV) and one non-polar impurity (impurity… (More)
Is this relevant?
2004
2004
AIM To study whether PC-407 [4-[5-naphthyl-3- (trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide] inhibits cell viability and… (More)
Is this relevant?